[关于T和B细胞对三种不同形式的人类乳头瘤病毒 (HPV) 疫苗接种反应的差异的研究进展]
Qi Peng1, Yangyang Li1, Jun Li1
1Department of Immunology, Zunyi Medical University, Zunyi 563000, China.
概括
子宫癌,通常是由高风险的人类乳头瘤病毒 (HPV) 类型16和18引起的,可以通过像Cervarix和Gardasil这样的疫苗来预防. 这些HPV疫苗显示出免疫反应,持续时间和最佳疫苗接种年龄的变化.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 宫癌是女性常见的恶性瘤,主要是由持续高风险的人类乳头瘤病毒 (HPV) 类型16和18引起的.
- 目前的预防策略包括双价值塞尔瓦里克斯,四价值加达西尔和9价值加达西尔-9疫苗.
研究的目的:
- 为了比较广泛使用的HPV疫苗之间的免疫学和实际差异.
- 阐明与T细胞反应,B细胞抗体水平和免疫持续时间相关的疫苗疗效变异.
主要方法:
- 用Cervarix,Gardasil和Gardasil-9接种疫苗后免疫反应的比较分析.
- 评估诸如T细胞效应分子,B细胞抗体标位,免疫持续时间和疫苗接种最佳年龄等因素.
主要成果:
- 这三种HPV疫苗在T细胞效应分子变化和B细胞抗体水平方面表现出不同的特征.
- 在疫苗类型之间观察到免疫反应的持续时间和疫苗接种最佳年龄范围的差异.
结论:
- 了解这些变异对于优化宫癌预防策略至关重要.
- 根据个体免疫反应和人口因素量身定制疫苗接种计划和疫苗选择,可以增强对HPV感染和宫癌的长期保护.
相关概念视频
01:51Vaccinations
44.4K
Overview
44.4K
01:30Cancer Vaccines
358
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
358
01:24B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K